These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19376703)

  • 1. Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists.
    Hammond M; Patterson JR; Manns S; Hoang TH; Washburn DG; Trizna W; Glace L; Grygielko ET; Nagilla R; Nord M; Fries HE; Minick DJ; Laping NJ; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 May; 19(10):2637-41. PubMed ID: 19376703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bradykinin B1 receptor antagonists: an alpha-hydroxy amide with an improved metabolism profile.
    Kuduk SD; Chang RK; Dipardo RM; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5107-10. PubMed ID: 18722115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).
    Boatman PD; Schrader TO; Kasem M; Johnson BR; Skinner PJ; Jung JK; Xu J; Cherrier MC; Webb PJ; Semple G; Sage CR; Knudsen J; Chen R; Taggart AK; Carballo-Jane E; Richman JG
    Bioorg Med Chem Lett; 2010 May; 20(9):2797-800. PubMed ID: 20363624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-Amino-9-aryl-3-cyano-4-methyl-7-oxo-6,7,8,9-tetrahydropyrido[2',3':4,5]thieno[2,3-b]pyridine derivatives as selective progesterone receptor agonists.
    Wang Y; Duraiswami C; Madauss KP; Tran TB; Williams SP; Deng SJ; Graybill TL; Hammond M; Jones DG; Grygielko ET; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 Sep; 19(17):4916-9. PubMed ID: 19664922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of orally active, pyrrolidinone-based progesterone receptor partial agonists.
    Washburn DG; Hoang TH; Frazee JS; Johnson L; Hammond M; Manns S; Madauss KP; Williams SP; Duraiswami C; Tran TB; Stewart EL; Grygielko ET; Glace LE; Trizna W; Nagilla R; Bray JD; Thompson SK
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4664-8. PubMed ID: 19616429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design of orally-active, pyrrolidine-based progesterone receptor partial agonists.
    Thompson SK; Washburn DG; Frazee JS; Madauss KP; Hoang TH; Lapinski L; Grygielko ET; Glace LE; Trizna W; Williams SP; Duraiswami C; Bray JD; Laping NJ
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4777-80. PubMed ID: 19595590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, synthesis, and structure-activity studies of tetrazole based growth hormone secretagogues.
    Hernández AS; Cheng PT; Musial CM; Swartz SG; George RJ; Grover G; Slusarchyk D; Seethala RK; Smith M; Dickinson K; Giupponi L; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5928-33. PubMed ID: 17869100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol-3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers.
    Vieira E; Huwyler J; Jolidon S; Knoflach F; Mutel V; Wichmann J
    Bioorg Med Chem Lett; 2005 Oct; 15(20):4628-31. PubMed ID: 16099654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonsteroidal progesterone receptor ligands (II); synthesis and SAR of new tetrahydrobenzindolone derivatives.
    Kurihara K; Shinei R; Tanabe K; Tabata Y; Kurata Y; Hoshiko S; Okonogi T
    Bioorg Med Chem; 2006 Jul; 14(14):4862-78. PubMed ID: 16580209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of tetrazole-based growth hormone secretagogue: the SAR studies of the O-benzyl serine side chain.
    Li J; Chen SY; Tao S; Wang H; Li JJ; Swartz S; Musial C; Hernandez AA; Flynn N; Murphy BJ; Beehler B; Dickinson KE; Giupponi L; Grover G; Seethala R; Sleph P; Slusarchyk D; Yan M; Humphreys WG; Zhang H; Ewing WR; Robl JA; Gordon D; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1825-9. PubMed ID: 18295486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsteroidal progesterone receptor ligands (I): synthesis and SAR of new tetrahydronaphthofuranone derivatives.
    Shinei R; Kurihara K; Tanabe K; Tabata Y; Kurata Y; Hoshiko S; Okonogi T
    Bioorg Med Chem; 2006 Jul; 14(14):4850-61. PubMed ID: 16580213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of 1H-tetrazole-1-alkanenitriles as potent orally bioavailable growth hormone secretagogues.
    Hernández AS; Swartz SG; Slusarchyk D; Yan M; Seethala RK; Sleph P; Grover G; Dickinson K; Giupponi L; Harper TW; Humphreys WG; Longhi DA; Flynn N; Murphy BJ; Gordon DA; Biller SA; Robl JA; Tino JA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2067-72. PubMed ID: 18282707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a tetrazole-based growth hormone secretagogue: 4-(hydroxybutyl)carbamic acid 2-{5-[1-(2-amino-2-methylpropionylamino)-2- benzyloxyethyl]tetrazol-1-yl}ethyl ester (BMS-317180).
    Li J; Chen SY; Li JJ; Wang H; Hernandez AS; Tao S; Musial CM; Qu F; Swartz S; Chao ST; Flynn N; Murphy BJ; Slusarchyk DA; Seethala R; Yan M; Sleph P; Grover G; Smith MA; Beehler B; Giupponi L; Dickinson KE; Zhang H; Humphreys WG; Patel BP; Schwinden M; Stouch T; Cheng PT; Biller SA; Ewing WR; Gordon D; Robl JA; Tino JA
    J Med Chem; 2007 Nov; 50(24):5890-3. PubMed ID: 17973363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tissue-selective nonsteroidal progesterone receptor modulator: 7,9-difluoro-5-(3-methylcyclohex-2-enyl)-2,2,4-trimethyl-1,2-dihydrochromeno[3,4-f]quinoline.
    Pedram B; van Oeveren A; Mais DE; Marschke KB; Verbost PM; Groen MB; Zhi L
    J Med Chem; 2008 Jul; 51(13):3696-9. PubMed ID: 18553958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxytocin analogues with amide groups substituted by tetrazole groups in position 4, 5 or 9.
    Manturewicz M; Grzonka Z; Borovicková L; Slaninová J
    Acta Biochim Pol; 2007; 54(4):805-11. PubMed ID: 18084651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11).
    Marzola E; Camarda V; Batuwangala M; Lambert DG; Calo' G; Guerrini R; Trapella C; Regoli D; Tomatis R; Salvadori S
    Peptides; 2008 May; 29(5):674-9. PubMed ID: 17822806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hit-to-lead optimization of disubstituted oxadiazoles and tetrazoles as mGluR5 NAMs.
    Wágner G; Wéber C; Nyéki O; Nógrádi K; Bielik A; Molnár L; Bobok A; Horváth A; Kiss B; Kolok S; Nagy J; Kurkó D; Gál K; Greiner I; Szombathelyi Z; Keseru GM; Domány G
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3737-41. PubMed ID: 20483612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Amino Acid-Isosteric α-Amino Tetrazoles.
    Zhao T; Kurpiewska K; Kalinowska-Tłuścik J; Herdtweck E; Dömling A
    Chemistry; 2016 Feb; 22(9):3009-18. PubMed ID: 26817531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR study of novel pseudo-steroids as potent and selective progesterone receptor antagonists.
    Jain N; Allan G; Linton O; Tannenbaum P; Chen X; Xu J; Zhu P; Gunnet J; Demarest K; Lundeen S; Murray W; Sui Z
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3977-80. PubMed ID: 19217285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.